Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics developer Luminex announced today that it has received clearance from the US Food and Drug Administration as well as CE-IVD marking for its in vitro diagnostic system, the Aries M1.

The M1 is a lower-throughout version of the company's Aries System, and is designed for use in smaller satellite labs. It extracts, amplifies, and detects nucleic acid targets from a variety of sample types, and can process up to six different samples and up to six PCR-based assays at a time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.